AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ERYTHROPOIETINE HUMAINE
13 registrations across 2 African markets— 2 active
Markets with ERYTHROPOIETINE HUMAINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| EPOMAX Solution injectable / 10000 UI / ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Jul 2017 |
| EPOMAX Solution injectable / 4000 UI / ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Apr 2017 |
| EPOMAX (IV/SC) Solution injectable / 2000 UI / ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Jun 2015 |
| EPOMAX Solution injectable / 2000 UI /0.5 ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Feb 2015 |
| EPOMAX (IV/SC) Solution injectable / 2000 UI / ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | May 2013 |
| HEMAX Pdre p.prep.injectable / 2000 UI | 🇹🇳Tunisia | BIO SIDUS S.A | expired | Jul 2011 |
| IOR EPOCIM Solution injectable / 2000 UI | 🇹🇳Tunisia | Center of Molecular Immunology | expired | Jul 2010 |
| EPOTIN 2000 Solution injectable / 2000 UI | 🇹🇳Tunisia | JULPHAR | expired | Jan 2007 |
| EPOTIN 4000 Solution injectable / 4000 UI | 🇹🇳Tunisia | JULPHAR | expired | Jan 2007 |
| HEMAX Pdre p.prep.injectable / 4000 UI | 🇹🇳Tunisia | BIO SIDUS S.A | expired | Dec 2002 |
| HEMAX Pdre p.prep.injectable / 2000 UI | 🇹🇳Tunisia | BIO SIDUS S.A | expired | Dec 2002 |
| EPOTIN SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| EPOTIN SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
ERYTHROPOIETINE HUMAINE in Africa — Regulatory Overview
ERYTHROPOIETINE HUMAINE is registered across 2 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 13 registrations, 2 (15%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.